Skip to main content
Funded Studies

Bernard M. Ravina, MD, MS

Chief Medical Officer at Voyager Therapeutics

Location: Cambridge, MA United States

Bernard Ravina is Vice President of Clinical Development at Voyager Therapeutics. Voyager is developing gene therapies for fatal and debilitating neurological disorders. Dr. Ravina has expertise across a number of CNS diseases and more than 15 years of clinical research experience in both academia and industry. Prior to Voyager, Dr. Ravina was Medical Director in Clinical Development at Biogen Idec. There, he worked on both small molecule drugs and biologics for the treatment of neurological disorders and was responsible for biomarker and clinical development plans in Parkinson’s disease, stroke, and neuropathic pain. Before joining Biogen Idec, Dr. Ravina was Associate Professor of Neurology, Director of the Movement and Inherited Neurological Disorders Unit, and Associate Chair of Neurology at the University of Rochester School of Medicine. He is the author of more than 80 scientific publications. Dr. Ravina holds an MD from Johns Hopkins University School of Medicine and a Masters in Clinical Epidemiology and Biostatistics from the University of Pennsylvania. He completed residency training in neurology and a fellowship in Parkinson's disease and movement disorders at the University of Pennsylvania.

Associated Grants

  • Biomarkers of Pioglitazone Effects in Parkinson's Disease (BioPEP)


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.